Back to top
more

Nu Skin Enterprises (NUS)

(Real Time Quote from BATS)

$6.97 USD

6.97
216,076

+0.42 (6.41%)

Updated Nov 11, 2024 10:48 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (211 out of 250)

Industry: Cosmetics

Zacks News

Nu Skin Q3 Earnings & Sales Miss Estimates, 2024 Guidance Cut

NUS' Q3 results show lower earnings and net sales amid macroeconomic pressures and challenges in the direct selling industry. Management lowers 2024 view.

Nu Skin Enterprises (NUS) Lags Q3 Earnings and Revenue Estimates

Nu Skin (NUS) delivered earnings and revenue surprises of -15% and 3.14%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Industry Outlook Highlights Coty, Helen of Troy, European Wax Center and Nu Skin

Coty, Helen of Troy, European Wax Center and Nu Skin are part of the Zacks Industry Outlook article.

E.l.f. Beauty (ELF) Q2 Earnings and Revenues Beat Estimates

e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 71.11% and 3.38%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Ansuiya Mohta headshot

4 Cosmetics Stocks Worth Watching Despite Industry Challenges

The Zacks Cosmetics industry is navigating a tough shopping environment. Nevertheless, COTY, Helen of Troy, European Wax Center and Nu Skin are leveraging innovations.

Nu Skin's Q3 Earnings Coming Up: Here's What You Should Know

NUS' Q3 results are likely to reflect the impacts of macroeconomic hurdles on consumer spending and customer acquisition.

Nu Skin Navigates Growth With Innovation Amid Industry Challenges

NUS drives growth through strategic initiatives, innovative product launches like MYND360 and the expanding Rhyz business amid macroeconomic woes.

NUS Stock Trading Below 200 & 50-Day SMA: What Should You Do Now?

Nu Skin is encountering persistent macroeconomic obstacles, weighing on consumer spending and customer acquisition.

Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?

Nu Skin is facing macroeconomic difficulties and a slow-moving direct-selling market. Foreign currency headwinds are also weighing on NUS.

NUS Stock Hurt by Customer Acquisition Challenges: How to Play Ahead?

Nu Skin encounters macroeconomic challenges related to volatile consumer spending and strong currency headwinds.

Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?

Nu Skin (NUS) has been battling persistent macroeconomic headwinds, which have been weighing on consumer spending and customer acquisition. Strong currency headwinds are also playing foul.

Are Options Traders Betting on a Big Move in Nu Skin (NUS) Stock?

Investors need to pay close attention to Nu Skin (NUS) stock based on the movements in the options market lately.

Nu Skin (NUS) Trims FY24 View Despite Q2 Earnings Beat

Nu Skin's (NUS) second-quarter 2024 results reflect lower earnings and net sales amid a dynamic macro-environment. Management lowers the 2024 guidance range.

Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Surpass Estimates

Nu Skin (NUS) delivered earnings and revenue surprises of 16.67% and 2.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin (NUS) Set to Report Q2 Earnings: What to Expect?

Nu Skin's (NUS) Q2 results are likely to reflect the impacts of macroeconomic challenges, including inflation and adverse currency fluctuations.

Nu Skin (NUS) Navigates a Tough Landscape on Growth Strategies

Nu Skin (NUS) has been dealing with challenges related to customer and affiliate acquisition. However, product launches, technological advancements and strength in the Rhyz business bode well.

Nu Skin (NUS) Troubled by Customer Acquisition Challenges

Nu Skin (NUS) has been battling persistent macroeconomic headwinds across most regions, which has affected customer and affiliate acquisition.

Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes

Nu Skin's (NUS) first-quarter 2024 results reflect challenges related to volatile currency movements, while cost-management efforts work well.

Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates

Nu Skin (NUS) delivered earnings and revenue surprises of 80% and 3.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin (NUS) Q1 Earnings Coming Up: Factors to Consider

Nu Skin's (NUS) first-quarter 2024 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations are a concern.

Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?

Smart Beta ETF report for PEY

Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?

Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why

Nu Skin (NUS) is battling macroeconomic challenges, with inflation putting pressure on consumer spending and customer acquisition. Management expects revenues to decline in 2024.